See the DrugPatentWatch profile for Soma
What is Soma 500mg?
Soma 500mg is a brand name for carisoprodol, a muscle relaxant used to treat pain and discomfort caused by acute musculoskeletal conditions [1]. It functions by altering the perception of pain in the central nervous system [2]. Soma is available by prescription only [1].
How does Soma work?
Carisoprodol is believed to work by affecting the central nervous system, specifically by blocking pain sensations between the nerves and the brain [2]. Its exact mechanism of action is not fully understood [2].
What are the risks and side effects of Soma?
Soma can cause side effects such as drowsiness, dizziness, and blurred vision [1]. It also carries a risk of dependence and abuse, and withdrawal symptoms can occur upon abrupt discontinuation [3]. Interactions with other central nervous system depressants, like alcohol or certain medications, can increase sedation and other adverse effects [1].
When does the patent for Soma expire?
Information regarding the specific patent expiry for Soma 500mg is not publicly available within the provided context. DrugPatentWatch.com tracks patent information for pharmaceuticals [4].
What are the alternatives to Soma?
Other muscle relaxants, such as cyclobenzaprine, methocarbamol, and baclofen, are available as alternatives to Soma [5]. The choice of an alternative often depends on the specific condition being treated and the patient's medical history [5].
How is Soma prescribed?
Soma is typically prescribed for short-term use to relieve pain associated with muscle strains, sprains, and other injuries [1]. It is usually taken by mouth, with or without food, two to three times a day [1].
What is the difference between Soma and carisoprodol?
Soma is the brand name for the drug carisoprodol [1]. Carisoprodol is the generic name for the active ingredient [1].
What regulatory information is available for Soma?
Carisoprodol is a controlled substance in some regions due to its potential for abuse and dependence [3]. Regulatory bodies monitor its use and distribution [3].
What clinical data is available for Soma?
Clinical studies have evaluated the efficacy and safety of carisoprodol in treating acute musculoskeletal pain [2]. These studies inform prescribing guidelines and risk assessments [2].
Where can I find more information on drug patents like Soma?
DrugPatentWatch.com provides comprehensive information on drug patents and exclusivity periods [4].
---
Sources:
[1] https://www.drugs.com/soma.html
[2] https://www.rxlist.com/soma-drug.htm
[3] https://www.addictioncenter.com/stimulants/carisoprodol/
[4] https://drugpatentwatch.com/
[5] https://www.medicalnewstoday.com/articles/325587